PUBMED FOR HANDHELDS

Journal Abstract Search


170 related items for PubMed ID: 8097579

  • 1. Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion.
    Kling MA, Rubinow DR, Doran AR, Roy A, Davis CL, Calabrese JR, Nieman LK, Post RM, Chrousos GP, Gold PW.
    Neuroendocrinology; 1993 Jan; 57(1):79-88. PubMed ID: 8097579
    [Abstract] [Full Text] [Related]

  • 2. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
    Kling MA, Roy A, Doran AR, Calabrese JR, Rubinow DR, Whitfield HJ, May C, Post RM, Chrousos GP, Gold PW.
    J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
    [Abstract] [Full Text] [Related]

  • 3. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications.
    Gold PW, Loriaux DL, Roy A, Kling MA, Calabrese JR, Kellner CH, Nieman LK, Post RM, Pickar D, Gallucci W.
    N Engl J Med; 1986 May 22; 314(21):1329-35. PubMed ID: 3010108
    [Abstract] [Full Text] [Related]

  • 4. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
    Gold PW, Kling MA, Khan I, Calabrese JR, Kalogeras K, Post RM, Avgerinos PC, Loriaux DL, Chrousos GP.
    Adv Biochem Psychopharmacol; 1987 May 22; 43():183-200. PubMed ID: 3035886
    [Abstract] [Full Text] [Related]

  • 5. Cerebrospinal fluid neuropeptides in mood disorder and dementia.
    Banki CM, Karmacsi L, Bissette G, Nemeroff CB.
    J Affect Disord; 1992 May 22; 25(1):39-45. PubMed ID: 1352520
    [Abstract] [Full Text] [Related]

  • 6. CRH in Cushing's syndrome.
    Müller OA, Stalla GK, von Werder K.
    Horm Metab Res Suppl; 1987 May 22; 16():51-8. PubMed ID: 2832289
    [Abstract] [Full Text] [Related]

  • 7. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E, Arvat E, Ramunni J, Colao A, Gianotti L, Deghenghi R, Lombardi G, Camanni F.
    J Clin Endocrinol Metab; 1997 Aug 22; 82(8):2439-44. PubMed ID: 9253314
    [Abstract] [Full Text] [Related]

  • 8. CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse.
    Banki CM, Karmacsi L, Bissette G, Nemeroff CB.
    Eur Neuropsychopharmacol; 1992 Jun 22; 2(2):107-13. PubMed ID: 1352999
    [Abstract] [Full Text] [Related]

  • 9. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment.
    Heuser I, Bissette G, Dettling M, Schweiger U, Gotthardt U, Schmider J, Lammers CH, Nemeroff CB, Holsboer F.
    Depress Anxiety; 1998 Jun 22; 8(2):71-9. PubMed ID: 9784981
    [Abstract] [Full Text] [Related]

  • 10. CSF somatostatin in anorexia nervosa and bulimia: relationship to the hypothalamic pituitary-adrenal cortical axis.
    Kaye WH, Rubinow D, Gwirtsman HE, George DT, Jimerson DC, Gold PW.
    Psychoneuroendocrinology; 1988 Jun 22; 13(3):265-72. PubMed ID: 2900533
    [Abstract] [Full Text] [Related]

  • 11. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA, Cutler GB, Chrousos GP, Nieman LK.
    JAMA; 1993 May 05; 269(17):2232-8. PubMed ID: 8386285
    [Abstract] [Full Text] [Related]

  • 12. Monoamine metabolites, corticotropin releasing factor and somatostatin as CSF markers in depressed patients.
    Widerlöv E, Bissette G, Nemeroff CB.
    J Affect Disord; 1988 May 05; 14(2):99-107. PubMed ID: 2452842
    [Abstract] [Full Text] [Related]

  • 13. CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures.
    Molchan SE, Hill JL, Martinez RA, Lawlor BA, Mellow AM, Rubinow DR, Bissette G, Nemeroff CB, Sunderland T.
    Psychoneuroendocrinology; 1993 May 05; 18(7):509-19. PubMed ID: 7903467
    [Abstract] [Full Text] [Related]

  • 14. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC, Nieman LK, Oldfield EH, Loughlin T, Barnes KM, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1989 May 05; 68(5):912-6. PubMed ID: 2541160
    [Abstract] [Full Text] [Related]

  • 15. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
    Newell-Price J, Perry L, Medbak S, Monson J, Savage M, Besser M, Grossman A.
    J Clin Endocrinol Metab; 1997 Jan 05; 82(1):176-81. PubMed ID: 8989255
    [Abstract] [Full Text] [Related]

  • 16. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L, Chrousos GP, Loriaux DL, Barnes K, Munson P, Nieman L, Schaison G.
    J Clin Endocrinol Metab; 1988 Feb 05; 66(2):290-3. PubMed ID: 2828406
    [Abstract] [Full Text] [Related]

  • 17. Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans.
    Geracioti TD, Orth DN, Ekhator NN, Blumenkopf B, Loosen PT.
    J Clin Endocrinol Metab; 1992 Jun 05; 74(6):1325-30. PubMed ID: 1317385
    [Abstract] [Full Text] [Related]

  • 18. Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression.
    Geracioti TD, Loosen PT, Orth DN.
    Biol Psychiatry; 1997 Aug 01; 42(3):165-74. PubMed ID: 9232208
    [Abstract] [Full Text] [Related]

  • 19. Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion.
    Ambrosi B, Bochicchio D, Fadin C, Colombo P, Faglia G.
    J Endocrinol Invest; 1990 Mar 01; 13(3):257-61. PubMed ID: 1973178
    [Abstract] [Full Text] [Related]

  • 20. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
    Hermus AR, Pieters GF, Pesman GJ, Smals AG, Benraad TJ, Kloppenborg PW.
    J Clin Endocrinol Metab; 1986 Apr 01; 62(4):634-9. PubMed ID: 3005353
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.